TG Therapeutics, Inc.

Overview

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company primarily focuses on developing therapies in the fields of hematology and oncology.

Therapeutic areas

API / Drug Master Files

TG Therapeutics, Inc. holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TRAPPSOL® CYCLO™Active2014-12-30
• CALCITONIN-SALMON (RDNA ORIGIN)Active1999-09-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TG Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.